Click here to read the notification from Pfizer advising of a supply interruption.

Please note the alternative product is being listed from 1 January 2020 under Section 29.

During the anticipated interruption period we will PROCURE the alternative product on demand as required.

Together we can make this a seamless and painless transition.

We thank you in anticipation of your ongoing support.

About The Author

Close